Stoke Therapeutics STOK Valuation Ratios and Share Stats

Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc (STOK) Financials

Statistics

Annual Quarterly

Year End 31 December 2023	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-455.761	-22.77	-19.225	-19.839	-31.97	-40.841	-43.228
Return on Equity (%)	860.372	-24.131	-19.621	-20.467	-34.059	-50.204	-60.798
Return on Invested Capital (%)	824.036	-24.694	-21.683	-20.798	-34.215	-51.985	-66.869
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	-814.728	-1192.472
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	-814.728	-1192.472
Book Value Per Share	-0.195	0.451	0.868	1.091	0.83	0.697	0.59
Earnings Per Share	-0.834	-0.054	-0.125	-0.199	-0.327	-0.381	-0.387
Cash Per Share	0.27	0.453	0.861	1.096	0.552	0.428	0.708
Working Capital Per Share	-0.271	0.445	0.859	1.078	0.808	0.802	0.683
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	0.047	0.032
EBIT Per Share	-0.834	-0.054	-0.125	-0.199	-0.327	-0.381	-0.387
EBITDA Per Share	-0.834	-0.054	-0.125	-0.199	-0.327	-0.381	-0.387
Free Cash Flow Per Share	-0.834	-0.051	-0.12	-0.199	-0.326	-0.372	-0.391

Liquidity Ratios

Year End 31 December 2023	2017	2018	2019	2020	2021	2022	2023
Current Ratio	0.514	43.025	55.117	25.727	13.374	7.774	6.987
Quick Ratio	0.484	42.724	54.248	25.147	12.825	7.313	6.535
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	6.67M	7.24M	32.86M	36.58M	36.9M	39.44M	N/A

Key Stats and Ratios

Year End 31 December 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	39.38M	39.43M	39.44M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-437.597	N/A	N/A	N/A	-625.569
Net Profit Margin (%)	N/A	N/A	N/A	-437.597	N/A	N/A	N/A	-625.569
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	8.572	N/A	N/A	N/A	5.431
Quick Ratio	N/A	N/A	N/A	8.046	N/A	N/A	N/A	5.018
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	702.05M
Price to Earnings Ratio	-6.71
Price to Sales Ratio	79.94
Price to Cash Ratio	3.67
Price to Book Ratio	4.4
Dividend Yield	-

Share Statistics

Shares Outstanding	52.12M
Average Volume (1 week)	1.31M
Average Volume (1 Month)	889.6k
52 Week Change	0.00%
52 Week High	17.58
52 Week Low	3.35

More Ratios Coming Soon!

Stoke Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions